ScholarIQanswers from OpenAlex & ORCID
Ersin Hatice Karslıoğlu
ResearcherPublications, citations & collaboration network
Ersin Hatice Karslıoğlu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ersin Hatice Karslıoğlu have?
ScholarIQindexed works
Ersin Hatice Karslıoğlu has 28 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ersin Hatice Karslıoğlu have?
ScholarIQcitation count
Ersin Hatice Karslıoğlu has 202 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ersin Hatice Karslıoğlu?
ScholarIQh-index
Ersin Hatice Karslıoğlu has an h-index of 6 in OpenAlex.
What is the i10-index of Ersin Hatice Karslıoğlu?
ScholarIQi10-index
Ersin Hatice Karslıoğlu has an i10-index of 4 in OpenAlex.
What is the ORCID of Ersin Hatice Karslıoğlu?
ScholarIQorcid
The ORCID for Ersin Hatice Karslıoğlu is on the source record.
What is the OpenAlex record for Ersin Hatice Karslıoğlu?
ScholarIQopenalex
The OpenAlex for Ersin Hatice Karslıoğlu is on the source record.
What are the most-cited papers on Ersin Hatice Karslıoğlu?
ScholarIQmost cited works
The Factors Contributing to Death Anxiety in Cancer Patients
Gokcen Gonen, Semra Ulusoy Kaymak, Eylem Şahin Cankurtaran, Ersin Hatice Karslıoğlu, Elvan Özalp, Haldun Soygür
Validating the Sexual Adjustment and Body Image Scale (Sabis) with Breast Cancer Patients
Elvan Özalp, Ersin Hatice Karslıoğlu, Ömer Aydemır, Haldun Soygür, Burcu Manisalı Erkek, Seda Ersoy Peker, Semra Ulusoy Kaymak
Explanatory Models of Illness, Help Seeking Behaviours and Related Factors in Patients with Schizophrenia: A Comparative Study from Two Different Provinces of Turkey
Hayriye Dilek Yalvaç, Elif Aktan Mutlu, Zeynep Kotan, İbrahim Özer, Ersin Hatice Karslıoğlu, Ali Çayköylü
Paliperidone Palmitate-induced Urinary Incontinence: A Case Report
Ersin Hatice Karslıoğlu, Elvan Özalp, Ali Çayköylü
Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐monthly: Preliminary findings of the first 3 months
Ersin Hatice Karslıoğlu, Zeynep Kolcu, Nisa İrem Karslioğlu, Ali Çayköylü